Prosperity Consulting Group, LLC

Position in ENLV — Enlivex Ltd.

CIK 1910398 OWINGS MILLS, MD

Position in ENLV

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$16,411

+$4,006 QoQ

Shares Held

17,647

0.0% QoQ

Ownership

0.105%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Prosperity Consulting Group, LLC holds $912,351 across 5 Biotechnology names. ENLV ranks #5 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,041	$344,435
2	REGN	Regeneron Pharmaceuticals, Inc.	360	$278,150
3	VRTX	Vertex Pharmaceuticals Inc / Ma	558	$249,169
4	BDTX	Black Diamond Therapeutics, Inc.	11,355	$24,186
5	ENLV	Enlivex Ltd. This page	17,647	$16,411

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$16,411	17,647	0.0%	Shares	Sole	2026-05-05
2025-12-31	$12,405	17,647	0.0%	Shares	Sole	2026-02-17
2025-09-30	$18,352	17,647	—	Shares	Sole	2025-11-14
No filing history on record for this holder in this stock.